Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 158 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1571 6.6 months Hepatocellular carcinoma 5 Biologic therapy
Chinese University of Hong Kong China 9/2012
Treatment Details: Patients: This phase 2 study involved 42 hepatocellular carcinoma patients. The median patient age was 57.5 years and 90% were male. Treatment: Patients were treated with the biologic
 
1572 6.6 months Recurrent GBM 4 Alternative
University of Lausanne Switzerland 9/2012
Treatment Details: Patients: This phase 3 study involved 120 previously treated patients with recurrent glioblastoma. The median patient age was 54 years and 77% were male. Treatment: Patients were treat
 
1573 6.6 months Metastatic melanoma 5 Biologic therapy
University of California, Irvine United States 12/2011
Treatment Details: Patients: This phase 2 study involved 32 metastatic melanoma patients. The median patient age was 65 years and 53.1% were male. Treatment: Patients were treated with the biologic thera
 
1574 6.6 months Advanced NSCLC 4 Chemotherapy
Consorcio Hospital General Universitario de Valencia Spain 3/2006
Treatment Details: Patients: This Phase III study involved a total of 254 patients. Patients were divided into two groups: Group A had 129 patients and Group B had 125 patients. The median age for patients i
 
1575 6.6 months metastatic colorectal cancer 3 Chemotherapy
Princess Margaret Hospital Canada 8/2005
Treatment Details: Patients: This Phase II study involved 19 patients with metastatic colorectal cancer. 17 had colon cancer and 2 had rectal cancer. Nine patients were men, ten patients were women, and the
 
1576 6.6 months Malignant Mesothelioma 4 Chemotherapy
University of Chicago Medical Center United States 11/1999
Treatment Details: Patients: This Phase II study involved 20 patients with malignant mesothelioma who could not be treated by surgery or radiation alone. Treatment: The treatment consisted of administration
 
1577 6.5 months Advanced NSCLC 4 Chemotherapy
Istituto Nazionale dei Tumori Italy 3/2003
Treatment Details: Patients: This Phase III trial involved 698 patients with advanced non-small-cell lung cancer. All patients were age 70 or older. Patients were divided into three groups. Group 1 comprise
 
1578 6.5 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
University of North Carolina United States 6/2006
Treatment Details: Patients: This Phase I/II trial involved a total of 26 patients with advanced non-small-cell lung cancer. There were 17 men and 9 women. The median age was 75.5. Treatment: The treatmen
 
1579 6.5 months Advanced NSCLC 5 Chemotherapy
Brigham and Women's Hospital United States 9/2007
Treatment Details: Patients: This phase II study involved 166 patients with progressive or recurrent advanced stage (IIIB or IV) non-small-cell lung cancer. All had received prior chemotherapy treatment. Th
 
1580 6.5 months Metastatic melanoma 3 Biologic therapy
Addenbrookes Hospital United Kingdom 10/2010
Treatment Details: Patients: This study involved 34 patients with metastatic melanoma. The median patient age was 62 years and 62% were male. Treatment: Patients were given the biologic agent vatalanib,
 
Page 158 of 187  | Previous Page  | Next Page